Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Volume

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Aug 20, 2021 10:49am

93 Views

Post# 33739562

RE:RE:RE:Volume

Those are the negatives, for sure. But there are also plenty of positives too. Glad you are OK! :)

Bucknelly21 wrote: I'm ok lol, just really bummed out how these guys have handled everything. They managed to isolate themselves from a massive bull market through bad market analysis for trogarzo, poor communication with the market, a bad strategy for reaching retail, burning analysts, offerings on bad terms ect. Maybe I just solved why it's the way it is lol

<< Previous

Bullboard Posts

Next >>

Yukon agency detects cyanide near Victoria Gold's Eagle mine